1. Calcium Channel Blockers for the Clinical Management of Hypertension

   • Massimo Volpe

   Editorial 11 October 2017 Pages: 1 - 3

2. Proprotein Convertase Subtilisin-Kexin Type 9 (PCSK9) Inhibitors and Cardiovascular Risk: Does a Further Analysis of the Fourier Trial Suggest Changes in the Target of Lipid Lowering Therapy?

   • Nazzareno Cervelli
   • Giuliano Tocci
   • Claudio Ferri

   Editorial 05 January 2018 Pages: 5 - 7

3. Comparison Among Recommendations for the Management of Arterial Hypertension Issued by Last US, Canadian, British and European Guidelines

   • Christina Antza
   • Ioannis Doundoulakis
   • Vasilios Kotsis

   Review Article 01 November 2017 Pages: 9 - 16

4. Excess Body Weight, Insulin Resistance and Isolated Systolic Hypertension: Potential Pathophysiological Links

   • Lanfranco D’Elia
   • Pasquale Strazzullo

   Review Article 02 November 2017 Pages: 17 - 23

   

5. How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension

   • Giuliano Tocci
   • Giovambattista Desideri
   • on behalf of the THYPERevolution Steering Committee

   Review Article Open access 02 December 2017 Pages: 25 - 34

   

6. Essential Hypertension and Functional Microvascular Ageing

   • Rosa Maria Bruno
   • Stefano Masi
   • Agostino Virdis

   Review Article 09 January 2018 Pages: 35 - 40

   

7. The Effects of Coenzyme Q10 Supplementation on Blood Pressures Among Patients with Metabolic Diseases: A Systematic Review and Meta-analysis of Randomized Controlled Trials

   • Reza Tabrizi
   • Maryam Akbari
   • Zatollah Asemi

   Review Article 12 January 2018 Pages: 41 - 50

   

8. Commentary to: “The Effects of Coenzyme Q10 Supplementation on Blood Pressures Among Patients with Metabolic Diseases: A Systematic Review and Meta-analysis of Randomized Controlled Trials”

   • Arrigo F. G. Cicero
   • Federica Fogacci
   • Alessandro Colletti

   Commentary 19 January 2018 Pages: 51 - 52

9. Perception, Knowledge, and Attitude toward Physical Activity Behaviour: Implications for Participation among Individuals with Essential Hypertension

   • Fatai Adesina Maruf
   • C. C. Ojukwu
   • M. O. Akindele

   Original Article 29 October 2017 Pages: 53 - 60

10. Anticoagulant Therapy in Atrial Fibrillation for Stroke Prevention: Assessment of Agreement Between Clinicians’ Decision and CHA2DS2-VASc and HAS-BLED Scores

    • Marzieh Balaghi-Inalou
    • Saeed Alipour Parsa
    • Sasan Andalib

    Original Article 26 October 2017 Pages: 61 - 64

    

11. Validation of Central and Peripheral Non-Invasive Hemodynamic Variables Using an Oscillometric Method

    • Darío Echeverri
    • Alejandro Pizano
    • Karen Moreno

    Original Article 28 October 2017 Pages: 65 - 77

    

12. Role of Acetyl Salicylic Acid in Controlling the DOCA-Salt Induced Hypertension in Rats by Stimulating the Synthesis of r-Cortexin in the Kidney

    • Uttam Kumar Maji
    • Pradipta Jana
    • Tamal Kanti Ghosh

    Original Article 06 January 2018 Pages: 79 - 88

    

13. Cardiac Biomarkers Release in Preadolescent Athletes After an High Intensity Exercise

    • A. Peretti
    • L. Mauri
    • G. Vignati

    Original Article 27 December 2017 Pages: 89 - 96

    

14. Association Between Atrial, Ventricular and Vascular Morphofunctional Alterations in Rheumatoid Arthritis

    • Alessandro Maloberti
    • Marta Riva
    • Guido Grassi

    Original Article 12 January 2018 Pages: 97 - 104

    

15. Abstracts from the 21st Annual Meeting of the European Council for Cardiovascular Research (ECCR), Lake Garda, 20–22 October 2017

    Abstracts 17 October 2017 Pages: 105 - 132

16. Reviewers 2017

    Acknowledgement to Referees 24 February 2018 Pages: 133 - 133